YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
The Australian stock market is navigating a period of cautious optimism, with shares hovering just above flat following a stronger-than-expected U.S. jobs report and recent advances past the 9,000-point mark on the ASX. In light of these d…
As the Australian market faces a turbulent start to the week, influenced by global economic tensions and significant movements in currency and commodities, investors are keenly observing how these factors might impact local equities. In su…
As the Australian market winds down for the holiday season, it faces a slight dip, likely due to profit-taking and early closures. Despite this quiet period, opportunities still abound for investors willing to explore beyond major indices.…
The Australian sharemarket has kicked off the last trading week of CY25 on a positive note, buoyed by gains in commodities and a festive spirit, with materials and energy sectors leading the charge. In this environment of strong sectoral p…
As global markets navigate the final month of 2025, investor sentiment is buoyed by hopes for an interest rate cut from the Federal Reserve, with small-cap stocks like those in the Russell 2000 Index experiencing a modest rise. Despite cha…
The Australian market has experienced a mix of reactions recently, with the IT sector making gains despite broader concerns about inflation and materials sector performance. In such an environment, growth companies with substantial insider…
As the Australian market navigates a mixed trading session, with materials leading and financials lagging, investors are keeping a close eye on potential opportunities amidst fluctuating sector performances. Penny stocks, though often seen…
The Australian market has recently experienced a boost in sentiment, with the ASX200 up 1.3% and nearly every sector showing gains, driven by positive tech earnings from global giants like NVIDIA. This improvement comes amidst ongoing conc…
As global markets grapple with economic uncertainties, including a record U.S. government shutdown and fluctuating consumer sentiment, Asian markets present a unique opportunity for investors interested in small-cap stocks. In this environ…
Australian shares are poised for a modest gain, buoyed by Wall Street's positive momentum following encouraging inflation data, while local market participants await Australia's own inflation report and key international trade discussions.…
As the Australian market experiences fluctuations driven by profit-taking and shifts in global economic sentiment, investors are closely watching sectors like Materials and Energy for opportunities. In this environment, identifying stocks…
PolyNovo (ASX:PNV) has appointed Robert Douglas to its Board of Directors, a move that brings decades of international medical device leadership into the mix. Investors are tuning in to see what his experience could mean for PolyNovo’s str…
PolyNovo Limited recently appointed Mr. Robert Douglas to its Board of Directors, bringing over thirty-five years of experience in medical device technology, digital health, and public company governance, with senior leadership roles at Re…
As Australian shares edge towards a slight dip, global markets remain on edge awaiting the Federal Reserve's anticipated rate cut decision. Amidst these market fluctuations, the term "penny stocks" may seem outdated, yet they continue to o…
As the Australian market navigates the tail-end of earnings season, influenced by a robust performance from Wall Street, investors are keenly assessing domestic reports to gauge potential opportunities. In this environment, growth companie…
The Australian market has experienced a subdued start to the week, with the XJO index down nearly half a percent as most sectors faced declines except for staples and energy. In this environment, identifying undervalued stocks can be cruci…
Australian shares are experiencing a downturn, with the ASX 200 futures showing a slight decline amid cautious sentiment surrounding the government’s Economic Reform Roundtable and reactions to Wall Street's recent highs. In such uncertain…
The Australian market recently experienced a downward slide as investors reacted to Reserve Bank comments cautioning against expectations of an August rate cut, while global uncertainties such as impending US tariffs add further complexity…
The Australian market has recently experienced a remarkable trading run, with the ASX hitting all-time highs despite some geopolitical tensions. As traders anticipate potential interest rate cuts and key speeches that could influence marke…
While PolyNovo Limited (ASX:PNV) might not have the largest market cap around , it saw a significant share price rise of 55% in the past couple of months on the ASX. The recent rally in share prices has nudged the company in the right dire…
Key Insights Using the 2 Stage Free Cash Flow to Equity, PolyNovo fair value estimate is AU$2.95 Current share price of AU$1.55 suggests PolyNovo is potentially 48% undervalued The AU$1.81 analyst price target for PNV is 39% less than our…
When you buy shares in a company, it's worth keeping in mind the possibility that it could fail, and you could lose your money. But when you pick a company that is really flourishing, you can make more than 100%. One great example is PolyN…
With the business potentially at an important milestone, we thought we'd take a closer look at PolyNovo Limited's (ASX:PNV) future prospects. PolyNovo Limited develops medical devices in the United States, Australia, New Zealand, the Unite…
Australian wound-care firm PolyNovo reported a significant surge in its August revenue on Monday, which more than doubled compared to the same month last year. The company's total sales for August 2023 amounted to 7.7 million Australian do…
PolyNovo Limited (ASX:PNV), might not be a large cap stock, but it saw a decent share price growth in the teens level on the ASX over the last few months. As a stock with high coverage by analysts, you could assume any recent changes in th…
Immuron Limited MELBOURNE, Australia, June 30, 2023 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company, is pleased to announce the transition of Paul Brennan…
PolyNovo Limited (ASX:PNV) shareholders might be concerned after seeing the share price drop 24% in the last quarter. But in stark contrast, the returns over the last half decade have impressed. In fact, the share price is 181% higher toda…
Key Insights Using the 2 Stage Free Cash Flow to Equity, PolyNovo fair value estimate is AU$2.17 Current share price of AU$1.41 suggests PolyNovo is potentially 35% undervalued Analyst price target for PNV is AU$2.25, which is 3.5% above o…
With the business potentially at an important milestone, we thought we'd take a closer look at PolyNovo Limited's (ASX:PNV) future prospects. PolyNovo Limited develops medical devices in the United States, Australia, New Zealand, the Unite…
PolyNovo Limited's (ASX:PNV) price-to-sales (or "P/S") ratio of 22.2x might make it look like a strong sell right now compared to the Medical Equipment industry in Australia, where around half of the companies have P/S ratios below 5.3x an…
PolyNovo (ASX:PNV) First Half 2023 Results Key Financial Results Revenue: AU$29.4m (up 62% from 1H 2022). Net loss: AU$3.82m (down by 336% from AU$1.62m profit in 1H 2022). AU$0.006 loss per share (down from AU$0.002 profit in 1H 2022). ea…
PolyNovo Limited (ASX:PNV), might not be a large cap stock, but it received a lot of attention from a substantial price increase on the ASX over the last few months. As a stock with high coverage by analysts, you could assume any recent ch…
When you buy a stock there is always a possibility that it could drop 100%. But on a lighter note, a good company can see its share price rise well over 100%. One great example is PolyNovo Limited (ASX:PNV) which saw its share price drive…
PolyNovo Limited (ASX:PNV) is possibly approaching a major achievement in its business, so we would like to shine some light on the company. PolyNovo Limited develops medical devices in the United States, Australia, New Zealand, the United…
To get a sense of who is truly in control of PolyNovo Limited (ASX:PNV), it is important to understand the ownership structure of the business. With 60% stake, individual investors possess the maximum shares in the company. In other words,…
PolyNovo Limited (ASX:PNV) insiders who purchased shares in the last 12 months were richly rewarded last week. The stock climbed by 15% resulting in a AU$142m addition to the company’s market value. As a result, their original purchase of…